Charmacy Pharmaceutical Co., Ltd.

HKEX:2289.HK

8.35 (HKD) • At close September 16, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Omzet 2,134.5592,269.0742,288.21,887.0791,800.6041,993.0142,130.9511,860.7591,784.6951,708.0881,913.2582,021.9882,191.8941,903.9421,891.8321,777.9491,761.7361,635.3971,564.5331,449.526753.515
Kosten van de omzet 1,984.892,130.3612,141.1171,765.5531,698.3971,861.1042,012.8671,741.4411,698.1141,574.0211,824.9651,875.1592,109.2141,779.2021,811.5841,678.3511,680.6471,551.7841,499.4971,378.121719.405
Brutowinst 149.669138.713147.083121.527102.207131.91118.085119.31886.581134.06788.293146.82982.68124.73980.24999.59881.08983.61365.03671.40534.11
Brutowinstmarge 0.070.0610.0640.0640.0570.0660.0550.0640.0490.0780.0460.0730.0380.0660.0420.0560.0460.0510.0420.0490.045
Onderzoek- en ontwikkelingskosten 000000000000000000000
Algemene en administratieve kosten 28.64318.8931.42318.31329.44718.95529.23816.46224.0322.47428.33225.82726.00523.49817.09421.66117.70622.67421.55615.6069.291
Verkoop- en marketingkosten 59.46563.00258.93453.89751.1352.31845.2840.69541.28536.11537.836.18335.85832.2229.64322.13521.79218.50420.09815.6598.939
Verkoop-, algemene en administratieve kosten 88.45982.34592.5672.48980.03871.52182.77960.26470.14858.00267.29462.89264.88354.67448.85143.79639.49841.17841.65431.26518.23
Overige kosten 000000000000000000-0.216-0.128-0.128
Bedrijfskosten 95.33489.1435.3180.77484.88478.53390.21964.72474.68364.1274.94868.60467.87357.68146.64943.58865.31838.3641.71830.68918.102
Bedrijfsresultaat 56.51651.7648.99744.4918.12656.29731.93656.1413.28971.90918.02481.05715.68468.03430.02253.43741.59142.43523.38240.1417.192
Bedrijfsresultaat ratio 0.0260.0230.0210.0240.010.0280.0150.030.0070.0420.0090.040.0070.0360.0160.030.0240.0260.0150.0280.023
Totaal overige inkomsten en kosten netto -24.254-16.60247.209-18.642-19.676-21.767-18.939-14.395-15.862-14.29-18.683-16.742-13.734-10.126-3.17-4.207-33.731-8.72-10-7.587-5.708
Inkomen voor belasting 32.26235.15796.20625.848-1.5534.5312.99741.746-2.57457.618-0.65964.3151.9557.90826.85249.2297.8633.71513.38232.55311.484
Inkomen voor belasting ratio 0.0150.0150.0420.014-0.0010.0170.0060.022-0.0010.034-00.0320.0010.030.0140.0280.0040.0210.0090.0220.015
Belastingkosten 7.278.80526.3735.2091.2588.5693.31410.8720.42215.3140.09818.9920.61614.9467.15712.4676.7358.4813.3866.1042.373
Nettowinst 24.99226.35369.83320.639-2.80825.9619.68330.873-2.15142.305-0.20745.641.84142.91919.69636.7631.12525.2349.99626.4499.111
Nettowinstmarge 0.0120.0120.0310.011-0.0020.0130.0050.017-0.0010.025-00.0230.0010.0230.010.0210.0010.0150.0060.0180.012
WPA (Winst Per Aandeel) 0.230.240.650.19-0.0260.240.090.29-0.020.39-0.0020.420.0170.40.180.340.0140.320.120.330.11
Verwaterde WPA 0.230.240.650.19-0.0260.240.090.29-0.020.39-0.0020.420.0170.40.180.340.0140.320.120.330.11
EBITDA 66.3961.70261.17759.85333.52969.98943.82766.04323.28283.0227.97889.54423.03474.80535.98658.95146.16246.84628.11745.1320.177
EBITDA ratio 0.0310.0270.0270.0320.0190.0350.0210.0350.0130.0490.0150.0440.0110.0390.0190.0330.0260.0290.0180.0310.027